Pictet Asset Management (Switzerland)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio BCRX Stock Details BCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$37.2M	Sell
2023 Q1	$46.9M	Buy
2022 Q4	$60.7M	Buy
2022 Q3	$60.7M	Sell
2022 Q2	$64M	Buy
2022 Q1	$83M	Buy
2021 Q4	$70M	Buy
2021 Q3	$172K	Buy